%0 Journal Article
%T Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis
%A Ekua W Brenu
%A Mieke L van Driel
%A Donald R Staines
%A Kevin J Ashton
%A Sharni L Hardcastle
%A James Keane
%A Lotti Tajouri
%A Daniel Peterson
%A Sandra B Ramos
%A Sonya M Marshall-Gradisnik
%J Journal of Translational Medicine
%D 2012
%I BioMed Central
%R 10.1186/1479-5876-10-88
%X The participants in the study comprised 65 (47.2£¿¡À£¿11.5£¿years) CFS/ME participants and 21 (45.2 ¡À9.3£¿years) non-fatigued controls. Flow cytometry protocols were used to assess NK subsets and NK cytotoxic activity at various time points that included baseline (T1), 6 (T2) and 12£¿months (T3). Cytokine secretions were measured following mitogenic stimulation of peripheral blood mononuclear cells.NK cytotoxic activity was significantly decreased in the CFS/ME patients at T1, T2 and T3 compared to the non-fatigued group. Additionally, in comparison to the non-fatigued controls, the CFS/ME group had significantly lower numbers of CD56brightCD16- NK cells at both T1 and T2. Interestingly, following mitogenic stimulation, cytokine secretion revealed significant increases in IL-10, IFN-¦Ã and TNF-¦Á at T1 in the CFS/ME group. A significant decrease was observed at T2 in the CFS/ME group for IL-10 and IL-17A while at T3, IL-2 was increased in the CFS/ME group in comparison to the non-fatigued controls. Overall cytotoxic activity was significantly decreased at T3 compared to T1 and T2. CD56brightCD16- NK cells were much lower at T2 compared to T1 and T3. IL-10 and IL-17A secretion was elevated at T2 in comparison to T1 and T3.These results confirm decreases in immune function in CFS/ME patients, suggesting an increased susceptibility to viral and other infections. Furthermore, NK cytotoxic activity may be a suitable biomarker for diagnosing CFS/ME as it was consistently decreased during the course of the 12£¿months study.
%K Chronic fatigue syndrome
%K Cytokines
%K Cytotoxic activity
%U http://www.translational-medicine.com/content/10/1/88/abstract